Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

XFOR

X4 Pharmaceuticals, Inc

CIK 0001501697 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$3.96
↑ 0.00 (0.00%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$373.51M
P/E Ratio
-1.91
EPS
-1.87
Dividend Yield
Not covered
52W Position
75%
Beta
2.45

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
2.22
P/S
46.11
EV/Revenue
28.59
ROE
-59.2%
Valuation data covers 8,494/9,463 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 75%
$1.35$4.83

Latest Financials

2025-12-31 FY
Revenue
$6.50M
Net Income
-$79.20M
Total Assets
$290.46M
Free Cash Flow
–

Recent news